UroGen Pharma URGN
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 17.98 | 83.87 | -0.47 | -20,263 | -24 | |
| 2025Q4 | 23.42 | 83.59 | -0.53 | -19,115 | -26 | |
| 2025Q3 | 19.95 | 88.26 | -0.69 | -27,386 | -33 | |
| 2025Q2 | 13.7 | 92.53 | -1.05 | -41,448 | -50 | |
| 2025Q1 | 11.06 | 93.73 | -0.92 | -36,914 | -44 | |
| 2024Q4 | 10.65 | 89.3 | -0.6 | -27,658 | -38 | |
| 2024Q3 | 12.7 | 84.1 | -0.49 | -17,545 | -24 | |
| 2024Q2 | 16.78 | 86.41 | -1 | -25,839 | -33 | |
| 2024Q1 | 15 | 86.42 | -0.87 | -25,740 | -32 | |
| 2023Q4 | 15 | 78.64 | -0.66 | -14,609 | -26 | |
| 2023Q3 | 14.01 | 74.7 | -0.56 | -13,500 | -22 | |
| 2023Q2 | 10.35 | 75.7 | -1.03 | -15,382 | -24 | |
| 2023Q1 | 9.24 | 82.75 | -1.3 | -22,045 | -30 | |
| 2022Q4 | 8.87 | 81.27 | -1.25 | -20,282 | -29 | |
| 2022Q3 | 8.32 | 80.64 | -1.13 | -18,087 | -26 | |
| 2022Q2 | 8.19 | 76.64 | -1.18 | -18,715 | -27 | |
| 2022Q1 | 8.71 | 79.02 | -1.25 | -21,957 | -28 | |
| 2021Q4 | 9.51 | 72.91 | -1.27 | -19,915 | -28 | |
| 2021Q3 | 16.82 | 77.59 | -1.35 | -23,440 | -30 | |
| 2021Q2 | 15.27 | 88.09 | -1.17 | -22,823 | -26 |